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Synthetic retinal analogues modify the spectral
and kinetic characteristics of microbial rhodopsin
optogenetic tools
N. AzimiHashemi1,2,*, K. Erbguth1,2,*, A. Vogt3,*, T. Riemensperger4, E. Rauch5, D. Woodmansee6,
J. Nagpal1,2, M. Brauner2,w, M. Sheves7, A. Fiala4, L. Kattner5, D. Trauner6, P. Hegemann3,
A. Gottschalk1,2,8 & J.F. Liewald1,2
Optogenetic tools have become indispensable in neuroscience to stimulate or inhibit
excitable cells by light. Channelrhodopsin-2 (ChR2) variants have been established by
mutating the opsin backbone or by mining related algal genomes. As an alternative strategy,
we surveyed synthetic retinal analogues combined with microbial rhodopsins for functional
and spectral properties, capitalizing on assays in C. elegans, HEK cells and larval Drosophila.
Compared with all-trans retinal (ATR), Dimethylamino-retinal (DMAR) shifts the action
spectra maxima of ChR2 variants H134R and H134R/T159C from 480 to 520 nm. Moreover,
DMAR decelerates the photocycle of ChR2(H134R) and (H134R/T159C), thereby reducing
the light intensity required for persistent channel activation. In hyperpolarizing
archaerhodopsin-3 and Mac, naphthyl-retinal and thiophene-retinal support activity alike
ATR, yet at altered peak wavelengths. Our experiments enable applications of retinal
analogues in colour tuning and altering photocycle characteristics of optogenetic tools,
thereby increasing the operational light sensitivity of existing cell lines or transgenic animals.
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S
ince the initial description of light activation of excitable
cells by Channelrhodopsin-2 (ChR2), both in cultured
mammalian neurons1–3 and in vivo in Caenorhabditis
elegans (C. elegans)4, optogenetics has revolutionized research in
various biological fields5–9. Optogenetics combines genetically
encoded, light-sensitive proteins and photostimulation for
exogenous control of specific cell functions1,2,10 in organotypic
cultures and intact animals4,11,12. ChR2 has proven highly useful
in the study of complex neuronal processes, due to the
millisecond precision of triggering neuronal activity1,13, as well
as the need for expression of just a single, small protein. In recent
years, various rhodopsin variants have been generated or
retrieved from novel algal genome databases7,14. They can be
divided into three main classes: (I) ion pumps (for example,
NpHR12,15,16, Mac and Arch3 (refs 17,18)) that pump Cl
inward or Hþ outward and thereby mediate hyperpolarization;
(II) cation channels (for example, ChR2 (refs 12,14,19,20)) that
function as membrane depolarizers; or (III) recently generated
ChR2 variants that show Cl conductance and can counteract
depolarization (for example, ChloC21 and iC1C2 (ref. 22)).
Rhodopsins are conjugates between a seven-transmembrane
domain apoprotein, forming an internal, hydrophobic pocket and
a photoisomerizable chromophore23. In Chlamydomonas
reinhardtii, where ChR was originally discovered, all-trans
retinal (ATR) is the incorporated pigment24,25. ATR naturally
occurs in mammalian tissue26,27 or can easily be supplied to
animals that do not have sufficient retinal (for example,
C. elegans, larval Drosophila). The ability of rhodopsins to be
activated by light is based on the characteristic absorption
spectrum of their chromophore, which depends on the molecular
environment of ATR inside the protein. When ATR (embedded
in a microbial rhodopsin) absorbs a photon, it isomerizes to
13-cis retinal, which causes a conformational change and gating
of the opsin28.
A recent focus of opsin research has been to shift its action
spectrum, either to long-wavelength absorption19,29–33 or to
wavelengths below its maximum of 470 nm (refs 33,34). This will
facilitate the independent activation of different cell types or allow
to combine photoactivation with the imaging of neuronal activity
using genetically encoded Ca2þ indicators (GECIs)35–38.
Currently used GECIs, based on GFP (green fluorescent
protein), are often excited at the same wavelength as ChR2,
apart from RCaMP38 or R-GECO39, which are based on red
fluorescent mRuby or mApple, respectively. Yet, R-GECO shows
photoswitching properties upon blue-light illumination, which
complicates its use in combination with ChR2. For spectral
separation, it would be desirable to shift the absorption of ChR to
a wavelength outside the GECI excitation range. However,
reaching this aim is complicated by the broad spectra of the
a-band and the blue-shifted smaller b-band. Thus far, this could
not be altered by mutating the protein backbone. An absorption
shift is also of interest for independent control in the same
animal, using a second rhodopsin. Last, shifting the absorption to
higher wavelengths facilitates the penetration depth of the
stimulating light in large animals, as it reduces scattering in the
tissue and absorption by haemoglobin.
Strategies to achieve a spectral shift or otherwise modified
properties include varying the retinal-binding pocket of the
apoprotein by single or multiple point mutations5,7,10,13–15,19,32
(for example, ChR2(T159C) (ref. 40)), generating chimeras of
different ChRs (for example, C1V1 (refs 14,20)), or screening
algal genomes for novel ChRs33. These variants have diverse
characteristics and may, in addition to or instead of colour
tuning, feature an extended lifetime of the open-state
(ChR2(C128S) (refs 41,42)) or high expression levels and high-
efficiency kinetics (ChR2(H134R/T159C) (refs 14,20)). However,
colour tuning is often accompanied by unwanted side effects,
such as decreased current amplitude43 or decelerated kinetics19.
An alternative option to shift the absorption spectrum or
generate kinetic changes is to modify the chromophore by
supplementing the medium or animal diet with retinal analogues.
Synthetic retinal analogues can be generated by altering the
length of the p-electron system or the structure of the polyene
‘backbone’ of the molecule; some of these have been tested for
ChR activity in living algae24,25,29,44. Reconstitution of Arch3 and
four ChR variants with A2 retinal, which carries an extra double
bond, resulted in functional pigments with enhanced long-
wavelength sensitivity29. Extensive work on bacteriorhodopsin
(BR)45–49 using synthetic retinal analogues suggests that many
other retinal analogues, particularly those with ring modi-
fications, might be applicable for the purpose of chromophore
substitution. However, in most cases, it was only shown that the
absorption maximum was shifted, without analysing the
rhodopsin function.
Due to its transparency, C. elegans is particularly well suited for
optogenetic analyses, and chromophore replacement is easily
achieved as ATR has to be provided as a supplement in the diet4.
Here we tested eight synthetic retinal analogues for their ability to
reconstitute the function of selected optogenetic tools, including
de- and hyperpolarizers. We analysed whether the analogues
would allow shifting the excitation wavelength or the extent of
light-induced effects. In ChR2(H134R) (ref. 50), the retinal
analogue Dimethylamino-retinal (DMAR) can reconstitute a fully
functional actuator and it expands its spectral sensitivity to longer
wavelengths. Due to the broad action spectrum, ChR2-DMAR
will likely not enable pairing with GECIs without optical
crosstalk, unless these are very blue-shifted. Behavioural and
electrophysiological analysis of body wall muscles (BWMs) in
C. elegans show significantly prolonged kinetics, leading to an
overall increase in charge transfer. Similar results were found
during electrophysiological studies on HEK cells. In other ChR
variants, such as ChR2(H134R/T159C), DMAR slows down the
photocycle even more, causing increased operational light
sensitivity of the cells, whereas it does not support function in
the spectrally red-shifted C1V1. DMAR also enhances ChR2
function in larval Drosophila, confirming that it can be used in
additional model systems. In combination with the hyper-
polarizers Arch3 and Mac, naphthyl-retinal and thiophene-
retinal show effects on C. elegans behaviour and on current
amplitudes in HEK cells that are comparable or even superior to
ATR, with naphthyl-retinal for example causing a significant blue
shift in Arch3. In summary, the use of retinal analogues is a
complementary strategy to obtain rhodopsin-based optogenetic
tools with modified characteristics, particularly in already existing
cell or animal lines.
Results
Synthetic retinal analogues affect the peak absorption of ChR2.
From a range of artificial retinal analogues that had been
investigated previously, we chose seven that caused a shift in the
absorption maxima of BR or ChR2 compared with ATR
(analogues II–VII (refs 47,51,52); analogue IX: trimethoxy-
retinal53). An additional analogue (VIII: thiophene-retinal) was
newly synthesized from a previously known precursor54 (Fig. 1a;
Supplementary Table 1; Supplementary Methods). The
functionality of these synthetic analogues was analysed in vivo
in BWMs of C. elegans expressing the channelrhodopsin
variant ChR2(H134R), which has a nearly twofold higher Naþ
conductance, a twofold lower degree of inactivation and
improved expression in C. elegans, resulting in larger photo-
current amplitudes4,55,56. The potential of the retinal analogues
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was evaluated by measuring changes in the body length due to
depolarization-induced contraction of the body following
illumination (2 s; 400–568 nm; 0.2 mW mm 2; see
Supplementary Fig. 1a for a titration of ATR concentration
required for maximal behavioural effects). In the absence of any
chromophore (Supplementary Fig. 1b) or in nontransgenic
animals (no ChR2(H134R) expression) supplemented with
retinoids (Supplementary Fig. 1c), photostimulation did not
cause any significant effects. In contrast, the presence of ATR
(250 mM; for details see Methods) and ChR2(H134R) resulted in
significant body contractions. The action spectrum featured a
maximum at about 480 nm with a 9.7±1.0% (n¼ 7) reduction in
body length (Fig. 1b). Some of the synthetic analogues facilitated
body contractions similar to ATR (retinal analogues II (DMAR),
VII), whereas others evoked weaker effects (V, IX) or even no
significant body contractions at all (III, IV, VI). Of all
chromophores tested, analogue VIII (thiophene-retinal) enabled
the strongest effect ( 13.6±0.9% (n¼ 9); 436 nm), hinting at
increased photocurrents and/or extended open-state lifetime
(Fig. 1b; Supplementary Fig. 2f). In addition, analogues V, VII,
VIII and IX caused a slight shift of the action spectrum maximum
to shorter wavelengths compared with ATR (more pronounced
function at 436 nm than at 480 nm).
DMAR red-shifts the action spectra of ChR2 variants. In
solution, free DMAR (II) showed a 67-nm bathochromic shift of
the peak absorption (449 versus 382 nm; Supplementary Fig. 3)
and seemed to be most promising for application in animals.
When incorporated into ChR2(H134R), it mediated light-evoked
body contractions in C. elegans at 480 nm, similar to those evoked
by ATR ( 10.2±0.4%; n¼ 10; Fig. 1b,c). However, the action
spectrum was broader and red-shifted. On further reduction of
the light intensity from 0.2 to 0.015 mW mm 2, DMAR still
supported strong contractions both at 480 and at 520 nm
( 11.6±0.4%; n¼ 12; Supplementary Fig. 2a,b), indicating a
420-nm red-shifted peak activity and overall improved opera-
tional sensitivity of the muscle cell (Supplementary Fig. 2c; see
below). Furthermore, DMAR showed excellent photostability
during multiple cycles of illumination (Supplementary Fig. 4).
A highly efficient variant of ChR2 is (H134R/T159C), which
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Figure 1 | ATR variants analysed in combination with ChR2 in C. elegans muscle. (a) Chemical structures of ATR and retinal analogues tested in this
study. (b) Action spectra of photostimulated body length changes (contractions; see inset) in animals expressing ChR2(H134R) in BWMs. The animals
were provided with 250 mM ATR (black; n¼ 7 (400/480 nm) or 8 (436/520/568 nm)) or retinal analogue II (n¼ 10), III (n¼ 10), IV (n¼ 10), V (n¼ 12),
VI (n¼ 10), VII (n¼ 12), VIII (n¼8 (480/568 nm) or 9 (400/436/520 nm)) or IX (n¼ 7 (400 nm), 8 (480/520 nm) or 9 (436/568 nm)). Body length
was analysed at five wavelengths (400, 436, 480, 520 and 568 nm; 0.2 mW mm 2) and changes were measured relative to the initial length of
unstimulated animals. Statistically significant differences are relative to ATR at the respective wavelength. (c) Time course of body length changes for
animals raised in the presence of ATR (left) and DMAR (right). The black bar marks the period of illumination (n¼ 7). (d) Action spectra of
photostimulated body length changes in animals expressing ChR2(H134R/T159C) in BWMs. The animals were provided with ATR (black; n¼8 (520 nm),
9 (400/436 nm), 10 (480 nm) or 12 (568 nm)) or DMAR (red; n¼ 12). Body length was analysed at five wavelengths (400, 436, 480, 520 and 568 nm)
and at reduced light intensity (0.004 mW mm 2). Changes were measured relative to the initial length of unstimulated animals. Statistically significant
differences are relative to ATR at the respective wavelength. (e) trelax values (see inset) of light-stimulated body length changes. Details as in b,d. Time
constants were obtained by non-linear fitting for monoexponential decay of body length. Displayed are means±s.e.m. All n values refer to animals.
Statistically significant differences are indicated (*Po0.05, **Po0.01, ***Po0.001; one-way analysis of variance (b); Student’s t-test (d)).
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Previously, we have shown that C. elegans expressing this
rhodopsin in BWMs exhibit stronger body contractions than
those expressing ChR2(H134R) at all wavelengths tested (400–
520 nm) (ref. 20). Therefore, it is possible to photostimulate cells
at very low light intensities. At 0.004 mW mm 2, ChR2(H134R/
T159C) mediated strong contractions with the ATR chromo-
phore, again reaching a maximum at 480 nm ( 9.8±0.4%;
n¼ 10; Fig. 1d; Supplementary Fig. 5), whereas at 520 nm
contractions were considerably smaller ( 3.9±0.1%; n¼ 8).
However, when animals were supplemented with DMAR, it still
enabled strong depolarization above 560 nm ( 9.9±0.6%;
568 nm; n¼ 12). Thus, ChR2(H134R/T159C) could be
efficiently activated even at 568 nm at low light intensity when
using DMAR instead of ATR. Furthermore, for both of these
ChR2 variants, we observed slowed kinetics of body relaxation
following the end of the light stimulus, if ATR was replaced by
DMAR (Fig. 1e). In animals expressing ChR2(H134R), the trelax
value increased from 580±50 ms (ATR; n¼ 7; 480 nm) to
850±80 ms (DMAR; n¼ 10; 520 nm). The same tendency was
observed in animals expressing ChR2(H134R/T159C), where
trelax increased from 780±50 ms (ATR; n¼ 10; 480 nm) to
2,052±180 ms (DMAR; n¼ 7; 520 nm). The slowing down of
body relaxation hints at a slower closing of ChR2, which causes
prolonged muscle contraction. This slightly delays acute
relaxation following the light stimulus, but in a way that does
not compromise the behavioural analysis.
The single-mutant ChR2(T159C) was shown to be highly
efficient in Xenopus oocytes40; however, in C. elegans it was
shown to be much less efficient20 and we could not improve this
using DMAR instead of ATR ( 6.3±0.9%; 480 nm; n¼ 10;
Supplementary Fig. 6a,b). C1V1(E122T/E162T), a chimera from
ChR1s of C. reinhardtii and V. carteri14, reliably permits
photodepolarization at red-shifted excitation between 520 and
580 nm, when supplemented with ATR20. However, surprisingly,
the C1V1–DMAR combination was non-functional and did not
promote body contractions in light ( 0.6±0.6%; 480 nm; n¼ 6;
Supplementary Fig. 6c,d). Thus, specific retinal analogues may
function in one, but not another, rhodopsin, possibly enabling
orthogonal combinations in animals.
DMAR slows down channel kinetics. To further characterize the
extent and kinetics of photocurrents in DMAR-supplemented
animals expressing ChR2(H134R) and ChR2(H134R/T159C), we
performed whole-cell patch-clamp studies in C. elegans BWMs.
At 470 nm, the transient peak current in animals supplemented
with DMAR reached 120±22 pA (n¼ 7; Fig. 2a,c), while in
animals cultivated with ATR, peak currents reached 155±22 pA
(n¼ 7). However, due to slower kinetics, the overall charge
transfer was higher with DMAR (Fig. 2d). In contrast, at 525 nm,
peak currents after photoactivation were significantly smaller for
ATR (86±13 pA; n¼ 7) versus DMAR supplementation
(142±28 pA; n¼ 8) and, furthermore, charge transfer at 525 nm
was larger for DMAR ( 126.0±29.2 pC; n¼ 8) than for ATR
( 72.8±10.7 pC; n¼ 7). These electrophysiological differences
most likely correspond to the increased efficiency of
ChR2(H134R) supplemented with DMAR at wavelengths
4470 nm, as discovered in behavioural assays (Fig. 1b), as well as
to the observed increase in operational light sensitivity of the
BWMs (Supplementary Fig. 2a,b).
In comparison, the ChR2(H134R/T159C)/ATR combination
generally caused much stronger photocurrents (470 nm; ATR:
421±112 pA; n¼ 8; DMAR: 195±46 pA; n¼ 7; Fig. 2b,c). Other
effects of replacing ATR with DMAR were similar to those
observed for ChR2(H134R). At 470 nm, overall charge transfer
was similar for both retinals (ATR:  268±82 pC; n¼ 8;
DMAR:  258±71 pC; n¼ 7; Fig. 2d). However, when switching
to higher wavelength, the overall charge transfer was increased
by 78% with DMAR (ATR:  196±40 pC; n¼ 7; DMAR:
 350±81 pC; n¼ 7; 525 nm).
In both ChR2 variants, DMAR led to a slowdown in channel
kinetics with increased rise time (¼ time to peak; Fig. 2e) and
tinactivation values (time constant of current decreasing from peak
to steady state; Fig. 2f). Channel closure decelerated with toff
values increasing from 41±3 ms (ATR; n¼ 7) to 293±22 ms
(DMAR; n¼ 7) in animals expressing ChR2(H134R) and from
112±16 ms (ATR; n¼ 7) to 708±74 ms (DMAR; n¼ 7) in
animals expressing ChR2(H134R/T159C) (Fig. 2g). In particular,
because the closing of the channel is influenced to a large extent, a
larger proportion of the channels accumulate ChR in the open
state (Supplementary Fig. 2a,b), causing higher photosensitivity of
DMAR-supplemented cells, as previously reported for step
function rhodopsins14,41,42,57.
Testing other retinal analogues. Besides DMAR, the retinal
analogues V and VII (naphthyl-retinal) mediated maximal body
contractions with ChR2(H134R), comparable to those achieved
with ATR (Fig. 1b). They also slightly slowed down time courses
of body relaxation after the light was turned off, increasing trelax
values from 520±110 ms (ATR; n¼ 10) to 770±80 ms (n¼ 12)
and 590±78 ms (n¼ 12), respectively (Fig. 1e). An even stronger
deceleration was obtained for thiophene-retinal (VIII; which also
enabled the strongest contractions) and for trimethoxy-retinal
(IX), featuring trelax values of 3,163±440 ms (n¼ 8) and
4,980±700 ms (n¼ 7). For all these four retinal analogues, based
on behavioural assays, the action spectra peaks featured a
hypsochromic shift from 480 nm (ATR) toward 436 nm.
When combining retinal analogues V and VII with the highly
efficient ChR2(H134R/T159C), contractions of  11.6±1.2%
(n¼ 10; Supplementary Fig. 7a,d) and  14.2±0.5% (n¼ 10;
Supplementary Fig. 8a,d) were achieved, respectively. In contrast,
combination with ChR2(T159C) elicited only reduced contrac-
tions ( 3.9±0.8%; n¼ 10; Supplementary Fig. 7c;  8.3±0.5%;
n¼ 10; Supplementary Fig. 8c, respectively). Because
ChR2(T159C) also reached only low effectiveness in combination
with ATR and DMAR as discussed above (Supplementary
Fig. 6a,b), our results suggest that this rhodopsin generally has
only low efficiency in C. elegans, at least with the retinal analogues
tested.
Absorption shifts and kinetic changes in HEK cells. Retinal
analogues can also be used in other systems to alter rhodopsin
properties. This should be readily achievable when there is little
or no endogenous retinal, as in Drosophila (see below). However,
mammalian cells may also benefit from retinal analogues to
modify rhodopsin properties for specific applications. Thus, we
attempted to reduce endogenous ATR levels in cultured HEK-293
cells by the removal of retinoid sources from the culture media,
and instead added retinal analogues. We then assessed the
functionality of wild-type ChR2 (as the H134R variant does not
express well in HEK cells) by recording photocurrents and
compared the electrophysiological parameters to those observed
in C. elegans, using the most promising retinal analogues.
Current–voltage relationships of patch-clamped HEK cells stably
expressing ChR2 were recorded at holding potentials ranging
from  60 to þ 40 mV during illumination (300 ms; 465 nm;
0.119 mW mm 2). Even without the addition of retinal, photo-
stimulation led to small currents at  60 mV ( 291±88 pA;
n¼ 6; Fig. 3f), suggesting that our attempted reduction of
endogenous ATR was incomplete. ChR currents without added
retinal, but supplemented with 10% fetal bovine serum, have been
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previously reported in HEK cells58. However, supplementation
with ATR (1 mM; Fig. 3a) led to strongly increased peak
currents of  1,674±271 pA (n¼ 7). HEK cells that had been
exposed to DMAR (1 mM; Fig. 3b), naphthyl-retinal (analogue
VII; Fig. 3c) or thiophene-retinal (analogue VIII; Fig. 3d)
exhibited reduced currents compared with those exposed to
ATR. This was most evident for DMAR, where current
amplitudes showed a significant decrease to  437±81 pA
(n¼ 6; Fig. 3f).
How this compares with the superior effects of DMAR in C.
elegans is currently unclear. The differences may be imposed by
using wild-type ChR2 versus ChR2(H134R), the size of the cells
(HEK cells B15–30 mm; BWMs B100 15 mm) and also the
different ionic compositions of the solutions used. Chromophore
access to the protein may furthermore depend on host-specific
factors or, though less likely, retinal analogues could be modified
in a host-specific manner. Other retinal analogues also had
different relative effectiveness in HEK cells compared with C.
elegans: naphthyl-retinal (VII) and thiophene-retinal (VIII)
supported ChR2 peak currents of  948±123 pA (n¼ 4) and
 1,066±120 pA (n¼ 7), respectively (Fig. 3f). Yet the strongest
photocurrents (nearly twice as large as ATR-dependent
currents) were induced by trimethoxy-retinal (analogue IX;
 3,068±768 pA; n¼ 5; Fig. 3e,f), which was not one of the
most effective retinals in C. elegans (Fig. 1b). While stationary
currents reached only 25% of the peak currents in the presence of
ATR, they reached 44% in the presence of DMAR and even 80%
with trimethoxy-retinal. These characteristics were related to slow
photocycle kinetics with significantly increased closing times




























































































































































































Figure 2 | Electrophysiological analysis of photocurrents in C. elegans BWMs. All animals were grown either on 250mM ATR or DMAR. Cells were
photoactivated by a 1-s light pulse (0.2 mW mm 2) at 470 or 525 nm, and currents recorded at a holding potential of 60 mV. (a) Mean inward currents
following light stimulation in animals expressing ChR2(H134R) in BWMs. During photoactivation, the peak current decays to a lower steady state level.
(b) Mean inward currents following light stimulation in animals expressing ChR2(H134R/T159C) in BWMs. (c) Mean peak currents of animals expressing
either ChR2(H134R) (left) or ChR2(H134R/T159C) (right) in BWMs. Numbers in the bars indicate n values for each experiment. (d) Charge transfer at
525 nm was increased in animals grown on DMAR. (e) The rise time (time to reach peak after onset of light stimulus; see inset on the right) featured
significantly increased values for animals grown on DMAR. (f) Comparison of time constants for inactivation during continuous illumination (tinact).
(g) Channel closure after the end of photostimulation featured significantly prolonged toff values in animals grown on DMAR. Time constants were
obtained by non-linear fitting for monoexponential decay of inward current changes. Displayed are means±s.e.m. (n values as indicated in c). All n values
refer to cells. Statistically significant differences are indicated (*Po0.05, **Po0.005, ***Po0.001; one-way analysis of variance).
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(Fig. 1e, Fig. 2g). In HEK cells, the toff measured for ATR was
18±2 ms (n¼ 8); this was increased to 26±2 (naphthyl-retinal;
n¼ 3), 97±12 (DMAR; n¼ 6), 217±35 (thiophene-retinal;
n¼ 8) and even 753±102 ms (trimethoxy-retinal; n¼ 6). Pre-
cisely resolved action spectra of the retinal analogues in HEK cells
were determined by measuring photocurrents at different
wavelengths (380–670 nm; holding potential  60 mV; Fig. 3h).
The DMAR action spectrum was broader and slightly shifted to
longer wavelengths (maximum 475 nm) compared with ATR
(maximum 465 nm). Thus, DMAR’s shift in the action spectrum
was much smaller than the shift of the absorption of free DMAR
compared to ATR (Supplementary Fig. 3). Nevertheless, photo-
currents at 460 nm were larger for cells grown on ATR, while
photocurrents at 550 nm were larger for cells grown on DMAR
(Fig. 3i). In contrast, the action spectra of cells cultivated with
naphthyl-retinal (VII), thiophene-retinal (VIII) and trimethoxy-
retinal (IX) were slightly blue-shifted, with maxima at 450, 460
and 460 nm, respectively (Fig. 3h). These results corresponded
well to the C. elegans behavioural data (Fig. 1b).
DMAR causes a red-shift of excitation in larval Drosophila.
Optogenetic neuronal depolarization using rhodopsins is a readily
functional technique in larval Drosophila8,59,60. Here we
expressed ChR2(H134R) (ref. 59) ubiquitously under control of
an actin promoter using the Gal4–UAS system61. Larvae raised
on medium containing 125mM ATR (nZ5) showed strong body
contractions during illumination, entirely immobilizing the
larvae, with a peak of efficiency at 465–525 nm at an irradiance
of 0.02 mW mm 2 (Fig. 4). Larvae raised on 125 mM DMAR
(n¼ 10) featured similar behaviour, but strong contractions were
achieved even at 0.01 mW mm 2 (P¼ 0.013). Though a high
percentage of ATR-fed larvae (nZ6) showed clear contractions at
this intensity, in contrast to DMAR-fed larvae the observed
465 nm
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Figure 3 | Electrophysiological analysis of ChR2 photocurrents in HEK cells. Current–voltage relationships of patch-clamped HEK cells grown in the
presence of 1mM ATR (a), DMAR (b), retinal analogue VII (c), VIII (d) or IX (e) were recorded at different holding voltages (60, 40,  20, 0, þ 20
and þ40 mV). Cells were illuminated at 465 nm for 300 ms (0.150 mW mm 2). The original traces are displayed. (f) Comparison of absolute current
amplitudes at 465 nm (0.150 mW mm 2; holding potential 60 mV) in the absence of any retinal (n¼6) or in the presence of ATR (n¼ 7), DMAR
(n¼6), analogue VII (n¼4), analogue VIII (n¼ 7) and analogue IX (n¼ 5). The mean peak currents (dark grey) and stationary currents (light grey) are
displayed. (g) toff values at 465 nm (0.150 mW mm 2; holding potential 60 mV). (h) Action spectra of peak photocurrents between 380 and 670 nm
(with additional 10% grey filter, equal photon flux of 2.81 1013 photons s 1 mm 2, holding potential  60 mV) for ATR (n¼ 7), DMAR (n¼ 7), analogue
VII (n¼6), analogue VIII (n¼4) or analogue IX (n¼6). Displayed are means±s.e.m. (i) Comparison of currents (holding potential 60 mV) in the
presence of either ATR (1 mM) or DMAR at 460 and 550 nm. At 460 nm (0.158 mW mm 2), currents in the presence of ATR were significantly larger,
while at 550 nm (0.132 mW mm 2), currents in the presence of DMAR were significantly larger. The original traces are displayed. All n values refer to cells.
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contractions were much weaker. No reliable contractions were
observed in the absence of retinoids (control with diluent EtOH;
nZ8) or for parental control strains carrying either
ChR2(H134R) construct only (UAS:ChR2(H134R)) or Gal4
construct only (Actin-Gal4; 0.1 mW mm 2; DMAR, nZ7;
ATR, nZ7). On long-wavelength stimulation (590 and
625 nm), a higher percentage of DMAR-fed larvae still featured
contractions at strong light intensities (0.1 mW mm 2; P¼ 0.011;
nZ9), whereas only about 30% of ATR-fed larvae contracted
strongly (nZ7). DMAR mediated strong body contractions even
at 625-nm illumination at lower irradiations where ATR was
much less effective and only led to strong contraction at the
highest intensity used. This demonstrates that, in this key model
organism, DMAR induces a red-shift in the efficient absorption
wavelength of ChR2 and mediates enhanced sensitivity.
Testing Arch3 and Mac in C. elegans and HEK cells. A wealth of
previous work has shown that retinal analogues modify the
properties of rhodopsin proton pumps, particularly BR62. Arch3
or Mac are better expressed in eukaryotes and commonly used to
hyperpolarize and inhibit excitable cells12,18. We expressed Arch3
in C. elegans BWMs and recorded effects of photostimulation on
body length between 400 and 600 nm (0.2 mW mm 2).
Hyperpolarization induced body elongation, as muscles became
inhibited and relaxed due to the internal hydrostatic pressure of
the C. elegans body. Although no photostimulation effects could
be observed in the absence of retinal (Supplementary Fig. 9), the
presence of ATR mediated a maximal increase in body length
during illumination at 568 nm (4.5±0.5%; n¼ 5; Fig. 5a). The
relaxation was maintained during the entire light pulse and
returned to the basal level after about 0.5–1 s in the dark
(Supplementary Fig. 9a). Most analogues were less efficient than
ATR with the exception of thiophene-retinal (VIII) that caused
increased sensitivity between 400 and 480 nm.
For Mac, ATR mediated a maximal increase in body length at
540 nm (4.5±0.6%; n¼ 7; Fig. 5b, Supplementary Fig. 9b).
Similar action spectra were obtained with naphthyl- and
thiophene-retinal, also peaking at 540 nm, but the operational
cellular sensitivities with these chromophores were reduced
compared with ATR (2.9±0.6%, n¼ 11; 2.2±0.5%, n¼ 7,
respectively). DMAR was also less efficient (540 nm; 3.1±0.3%;
n¼ 10), especially in the blue, whereas it nearly reached ATR
efficiency close to 600 nm. Trimethoxy-retinal (IX) showed no
activity in Mac.
In a parallel set of experiments, HEK cells transfected with
Arch3 were tested in combination with the same retinal
analogues. Generally, Arch3 produced rather small photocurrents
in this expression system compared with ChR2 at the respective
action spectra peaks (Fig. 5c; 0.150 mW mm 2). This may be
explained by a more efficient targeting of ChR2 to the plasma
membrane in the stable cell line (compared with transiently
transfected Arch3-expressing HEK cells) and by the fact that
passive ion transfer through channels is generally larger than
vectorial transport through pumps (one ion per absorbed
























































































































































































































Figure 4 | Dependency on wavelength and light intensity in Drosophila larvae. Larvae expressing ChR2(H134R) ubiquitously (Actin-Gal44UAS:
ChR2(H134R)) showed reliable light-induced contractions at 465 and 525 nm at an irradiance of 0.02 mW mm 2 when ATR (125 mM) was supplied in the
diet (nZ5). At a wavelength of 525 nm, larvae fed with DMAR (125mM) contracted reliably even at 0.01 mW mm 2 (n¼ 10), whereas ATR-fed larvae
showed reliable contractions at a light intensity of 0.02 mW mm 2 (P¼0.013, w2-test). At longer spectral wavelengths (590 and 625 nm), more than 60%
of DMAR-fed larvae (nZ14) still showed contractions at strong light intensities (0.1 mW mm 2), whereas only about 30% of ATR-fed larvae (nZ7)
contracted at these wavelengths. No reliable contraction could be observed when only the diluent (EtOH) was supplied to the food (nZ8). Control strains
carrying either the UAS:ChR2(H134R) construct only or the Actin-Gal4 construct only did not show contractions, with either DMAR or ATR (nZ7). Body
contractions were classified as ‘weakly contracted’ when animals showed clear contractions, but were still able to move, and ‘strongly contracted’ when
animals were completely immobilized during the first seconds of irradiation. All n values refer to animals.
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in the absence of retinal showed minor currents (7±2 pA; n¼ 6;
Fig. 5c), although measured in retinoid-deprived culture medium
without FCS (fetal calf serum). Similar to C. elegans, DMAR and
analogue IX did not enable any currents (both 0±0 pA; n¼ 4).
The largest effects were obtained in the presence of analogue VIII
(42±13 pA; n¼ 5), while analogue VII (30±7 pA; n¼ 4) showed
the same effectiveness as ATR (34±5 pA; n¼ 14). Both analogues
that showed functionality featured a large blue shift in the action
spectrum (30 and 60 nm shifts for analogues VIII and VII,
respectively), which was comparable to the shifts observed for
Arch3 in C. elegans BWMs (Fig. 5d). We could not compile an
analogous data set for Mac, as this protein showed poor plasma
membrane targeting.
Discussion
We characterized eight synthetic retinal analogues for their
potential to reconstitute and modify function in several
rhodopsin-based optogenetic tools, in vivo, compared with the
natural chromophore ATR. Our results (summarized in Table 1)
show, first, that artificial analogues of ATR can be successfully
used for colour tuning of rhodopsins; second that the colour shifts
varied between different rhodopsins; and third that analogues
may also affect photocycle kinetics.
DMAR promoted ChR2-evoked behavioural effects in
C. elegans with a significantly red-shifted action spectrum
compared with ATR (maxima for ATR at 480 nm and DMAR
at 500–568 nm). The light sensitivity of cells was increased,
particularly at the red edge of the spectrum (12 times compared
with ATR). An even bigger sensitivity gain and a 40-nm spectral
red-shift was obtained for the ChR2(H134R/T159C)/DMAR
combination. At all wavelengths tested, strong body contractions
could be achieved even at 0.004 mW mm 2, 50- to 100-fold less
light than that used to achieve similar effects with ChR2(H134R)/
ATR. This was due to the improved expression of ChR2(H134R/
T159C) (ref. 20) and extended open-state life time, resulting in
more charge transfer per photocycle.
Thus, DMAR provides an alternative to achieving higher
operational light sensitivity of the cells at red-shifted wavelengths,
at still comparably fast on and off switching of the channel.
Provided that DMAR can be supplied to organotypic cultures or
animals in amounts sufficient to replace the endogenously present
ATR, DMAR may facilitate photostimulation deep within tissue,
with red light that is less prone to scattering. In C. elegans, the
increased operational light sensitivity of BWMs combined with
the red-shifted spectrum furthermore helps to avoid photophobic
responses that are evoked during prolonged activation with
intense blue light63 and which may interfere with specific, ChR2-
evoked behavioural effects in neuronal circuit studies.
One important model system in the neurosciences, Drosophila,
has been particularly ‘resistant’ to the use of wild-type ChR2 in
the central nervous system of adult flies. Recent work using the
red-shifted variants ReaChR32 or Chrimson33 could overcome
this limitation to some degree, possibly due to the higher
operational cellular sensitivity, red-shifted absorption and ease of
tissue penetration of red light. We show that already existing
ChR2 Drosophila lines can be rendered more sensitive to red light
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Figure 5 | Effects on C. elegans BWMs and HEK cells expressing Arch3 and Mac. C. elegans or HEK cells were cultivated in the presence of ATR or various
retinal analogues. The chromophores were provided at 100 mM (C. elegans) or 1mM (HEK cells). (a) Action spectra of body length changes (elongations;
see inset) in C. elegans expressing Arch3 in BWMs. The 2-s illumination was carried out at 400, 436, 480, 520, 540 568, 580 and 600 nm
(0.2 mW mm 2). Body length changes were measured relative to the initial length of unstimulated animals. Displayed are means±s.e.m. for ATR (n¼ 5),
DMAR (n¼ 5), analogue VII (n¼ 11), analogue VIII (n¼ 9) or analogue IX (n¼ 7). (b) Action spectra of body length changes in C. elegans expressing Mac
in BWMs. Illumination and body length measurements were carried out as for Arch3 (a). Displayed are means±s.e.m. for ATR (n¼ 7), DMAR (n¼ 10),
analogue VII (n¼ 11), analogue VIII (n¼ 7) or analogue IX (n¼ 7). (c) Comparison of absolute peak current amplitudes in HEK cells at a holding potential of
0 mV and at the respective action spectra maxima for ATR (565 nm, n¼ 14), DMAR (no signal in action spectra, n¼4), analogue VII (500 nm, n¼4),
analogue VIII (530 nm, n¼ 5), analogue IX (no signal in action spectra, n¼4) and in the absence of retinal (565 nm, n¼6). Amplitudes of Arch3
were recorded at the highest transmission of 0.080–0.110 mW mm 2 (at maximal transmission between 500 and 565 nm). Displayed are means±s.e.m.
(d) Action spectra of HEK cells transfected with Arch3-EGFP in presence of ATR (n¼ 3), analogue VII (n¼ 7) or analogue VIII (n¼ 8). DMAR and
analogue IX were also tested but did not enable photocurrents. Displayed are stationary currents following photostimulation at a holding potential of 0 mV
(equal photon flux for each wavelength of 2.81 1014 photons s 1 mm 2). In (a) and (b) n values refer to animals, in (c) and (d) n values refer to cells.
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rather inefficient in the central nervous system of adult
Drosophila could not be overcome. A recent ChR variant (ChR-
XXL) with good expression and extremely long photocycle
provides a very promising solution for this problem57.
The retinal analogues V, VII, VIII and IX were also functional
and caused a modest blue-shift in the ChR2 action spectrum
(436 nm; Table 1). These shifts are likely not distinct enough to
allow a meaningful combination with GECIs for Ca2þ imaging
without the cross-activation of ChR2 (Supplementary Fig. 10). On
the other hand, analogues III, IV and VI did not mediate relevant
muscle contractions, possibly because these chromophores only
weakly bind to and weakly stabilize ChR for trafficking.
Significant deceleration of channel kinetics was observed for
analogues VIII and IX, with the latter mediating particularly
strong currents in HEK cells. Possible reasons for altered channel
kinetics are that the retinal analogues are embedded slightly
twisted in the apoprotein and/or that they interact differently
with side chains, thus changing the transition barriers between
photocycle intermediates; this needs to be analysed by spectro-
scopy on isolated and reconstituted protein. Determining how
retinal analogues influence kinetic and spectral properties may
permit rational design of further synthetic analogues.
Interestingly, retinal analogues had different effects on ChR2
(ATR: maximum 465 nm) compared with the red-shifted
hyperpolarizer Arch3 (ATR: maximum 560 nm) in HEK cells:
Analogues that were functional in ChR2 did not support Arch3
function (II, IX). A comparison of currently available crystal
structures of C1C2 (a chimera between ChR1 and ChR2) and
Arch2 indicates that the spacious analogue IX (covalently docked)
may be less stabilized in Arch, and that steric clashes can be
observed which could hinder binding (Supplementary Fig. 11).
Our findings suggest that slight modifications of the chromophore
often lead to a slowdown of photocycle kinetics. This can be
deteriorating for ion pumps that depend on high turnover, but not
for channels that rather exhibit longer open-state lifetimes.
Furthermore, the opsin shift (absorption maximum of unbound
retinal relative to the rhodopsin action spectrum maximum) in the
case of Arch3 by analogues VII (360-500 nm) and VIII (400-
530 nm) was less pronounced than for ATR (380-560 nm). The
opsin shift might be limited in red-shifted optogenetic tools where
it is in part caused by polar amino acids in the binding pocket64.
Most retinal analogues we tested were already more polar near the
ring than ATR. Thus, the polar characteristics of the analogues
may not sum up with effects by more polar amino acids in ‘red-
shifted’ rhodopsins that prevent DMAR binding in the case of
C1V1 (ref. 20). The non-functionality of certain retinals in some
of the opsins, but not in others, opens up a new avenue for
orthogonal retinal/rhodopsin pairs where the respective retinals
interact specifically and exclusively only with one of the
rhodopsins. As a novel strategy, it is conceivable to
simultaneously use two (or more) rhodopsins in the same
animal that are each supplemented with a specific retinal
analogue. This might allow for the combined use of different
rhodopsins with specifically altered properties.
Replacing ATR in a tissue or in an organism by a synthetic
analogue requires the procurement and exogenous application of
the chromophore. This is not a significant limitation of the
approach if the retinal analogue is able to out-compete
endogenous ATR for binding to the optogenetic tool. It is
particularly straightforward in model systems such as C. elegans,
which need to be supplemented with the chromophore anyway.
Optogenetic tools with modified action spectra may promote
the possibility of stimulating cells with ChR and simultaneously
imaging Ca2þ . This is precluded for most GECIs by the broad
action spectra of available rhodopsins (Supplementary Fig. 10).
Only the novel Ca2þ sensor RCaMP has so far been applied
without the unintended co-activation of ChR2 (refs 1,18,38,65,66).
Testing more retinal analogues may allow the identification of
additional combinations of optical sensors and rhodopsin
actuators. The analogues we characterized unfortunately do not
permit enough spectral shift to achieve this goal.
In this work, we carried out a survey of entirely artificial,
synthetic retinal analogues directly in mammalian cells and
in vivo in C. elegans and Drosophila larvae. Our results illustrate
that matching ChR variants and other rhodopsins with synthetic
retinal analogues can generate optogenetic tools with modified
characteristics with respect to absorption spectra and kinetics.
Thus, the study opens the door to further optimization by
combining rhodopsin-based optogenetic tools with (synthetic)
retinal analogues. This may help to improve the performance of
such tools, with the potential for developing additional combina-
tions that might offer the particular characteristics required for a
specific application.
Methods
Synthesis of retinal analogues. The synthesis of some of the retinal analogues
has been described previously46. Details of the synthesis of compounds II–IX, as
well as 1H NMR, 13C NMR and HMRS data, can be found in Supplementary
Methods. Absorption spectra were measured in isopropanol (0.02 mM) with
BioSpectrometer Basic (Eppendorf, Germany).
Table 1 | Summary of key results presented in this study.
ATR II III IV V VI VII VIII IX
ChR2(H134R) 480 400–520   436  436 436 436 C. elegans Action maximum (nm)
465 475 450 460 460 HEK
580 850   770  590 3163 4980 C. elegans trelax (ms)
18 97 26 217 753 HEK toff (ms)
þ þ þ þ þ þ   þ  þ þ þ þ þ þ þ C. elegans Effect strength
þ þ þ þ þ þ þ þ þ þ þ þ HEK
Arch3 568 580 480 520  C. elegans Action maximum (nm)
560  500 530  HEK
þ þ þ þ þ þ þ þ  C. elegans Effect strength
þ  þ þ þ  HEK
Mac 540 540/580 540 440–540 568 C. elegans Action maximum (nm)
þ þ þ þ þ þ þ þ  C. elegans Effect strength
ChR2(HR/TC) 480 520 436 436 C. elegans Action maximum (nm)
ChR2(TC) 436 400–580 436 436 C. elegans Action maximum (nm)
C1V1 540  C. elegans Action maximum (nm)
ATR, all-trans retinal; C. elegans, Caenorhabditis elegans; ChR2, channelrhodopsin-2.
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C. elegans strains. C. elegans strains were cultivated in the dark at 20 C on
nematode growth medium (NGM) plates in the presence of the E. coli strain OP50-
1 (ref. 67).
The following transgenic strains were used:
ZX299: lin-15(n765ts ); zxEx22[pmyo-3::ChR2(H134R)::YFP; lin-15þ ] (ref. 50);
ZX980: wild type; zxEx516[pmyo-3::C1V1(E122T; E162T)::YFP; pmyo-2::mCherry];
ZX1166: wild type; zxEx536[pmyo-3::ChR2(T159C)::YFP; pmyo-2::mCherry];
ZX1167: wild type; zxEx537[pmyo-3::ChR2(H134R; T159C)::YFP; pmyo-2::mCherry]
(all from ref. 20); ZX1483: lin-15(n765ts); zxEx820[pmyo-3::Arch3::2xmyc-tag;
lin15(þ )]; ZX1484: lin-15(n765ts); zxEx821[pmyo-3::Mac::2xmyc-tag; lin15(þ )]
C. elegans behavioural assays. C. elegans strains were kept under light-excluding
conditions on standard NGM plates (5.5 cm diameter; 8 ml NGM). Per plate, 300ml
of OP50-1 culture containing either 250mM (ChR2) or 100mM (Arch3, Mac) of
ATR or retinal analogue (diluted in ethanol) were spread and allowed to dry, before
worms were added. The day before the experiment, transgenic L4 larvae were
selected for muscle fluorescence and light reactivity under a Leica MZ16F dissection
scope and transferred to fresh chromophore plates. Resulting young adults were
again selected and transferred to NGM plates with OP50-1 bacteria provided with
either ATR or the respective retinal analogue at least 2 h before the experiment.
For measurements of contractions and elongations20,67, worms were
individually placed on plain NGM plates and assayed on an Axiovert 200
microscope with  10 magnification (Zeiss, Germany). For colour illumination,
the light of a 100-W mercury arc lamp was channelled through a beamsplitter
(F38–651, AHF Analysentechnik, Tübingen, Germany) and excitation BP filters of
400±10 nm, 436±10 nm, 480±10 nm, 520±10 nm, 540±10 nm, 568±10 nm,
580±10 nm or 600±10 nm (Edmund Optics, Karlsruhe, Germany). Alternatively
a rhodamine (540±35 nm) or a Cy5 filter (620±30 nm) was used (AHF
Analysentechnik, Tübingen, Germany). Intensities were individually adjusted using
the lamp intensity control panel and neutral density filters (Zeiss, Germany), as
defined by the S120 UV Sensor with PM 100 power meter (Thorlabs, Dachau,
Germany). In consecutive recordings of initially forward-moving animals, using a
CMOS camera (DCC1545M, Thorlabs, Dachau, Germany), HBO illumination on-
and offset were defined by a computer-controlled shutter (Sutter Instruments,
USA). Only those movies were taken into account in which the animals did not
display backward locomotion at least until the end of the light stimulus. All frames
were extracted for body length using a custom written LabView script11, and the
percentage length relative to the body size of each worm before illumination was
calculated and averaged20. Displayed are means±s.e.m.
Electrophysiology in C. elegans. C. elegans strains were kept under light-
excluding conditions on high-growth medium plates (9 cm diameter; 25 ml high-
growth medium). Per plate, 650 ml of OP50-1 culture containing ATR or DMAR
(250 mM; diluted in ethanol) were spread and allowed to dry before worms were
added. Electrophysiological recordings were performed from dissected BWMs4.
After dissection, cells were treated for 8 s with 0.5 mg ml 1 collagenase (Sigma,
Germany) in C. elegans Ringer’s (CRG; 150 mM NaCl, 5 mM KCl, 5 mM CaCl2,
1 mM MgCl2, 10 mM glucose, 15 mM HEPES (pH 7.35), 340 mOsm) and washed
with CRG. Cells were clamped to a holding potential of  60 mV using an EPC10
amplifier with head stage and Patchmaster software (HEKA, Germany). The bath
solution was CRG, the pipette solution was 120 mM KCl, 20 mM KOH, 4 mM
MgCl2, 5 mM TRIS-HCl, pH 7.2, 0.25 mM CaCl2, 4 mM ATP, 36 mM sucrose, and
5 mM EGTA, 315 mOsm.
Light activation was performed using an LED (light-emitting diode) lamp at a
wavelength of 470 nm (KSL-70, Rapp OptoElectronic, Germany) or 525 nm
(LumenLED, Prior Scientific Instruments, Germany), and controlled by
Patchmaster software (HEKA, Germany). Light intensity applied was
0.2 mW mm 2 using lamp intensity control panel and neutral density filters (Zeiss,
Germany) as defined by an S120 UV Sensor with PM 100 power meter (Thorlabs,
Dachau, Germany). Only previously unstimulated animals were used for each
single experiment. For the analysis, ASCII data files were analysed with Origin
software (OriginLab, Northampton, MA, USA).
Electrophysiology in HEK cells. Serum-free culture of HEK cells. Advanced
DMEM (Life Technologies, USA) was used as culture medium without supple-
mentation with FCS to prevent contamination by retinoids from serum. Culture
flasks (TPP, Switzerland) were coated with poly-L-lysine (Biochrome, Germany) to
maintain adhesion. Coverslips were shortly heated in fire, coated with poly-L-lysine
and put into dishes with 2 ml advanced DMEM per dish. Measurements were
accomplished using the stable ChR2-YFP cell line68 and HEK-293 cells (DSMZ no.
ACC-305). After 1 week, the expression of ChR2 was induced by the addition of
tetracycline (to a final concentration of 2 mM), whereas the expression of Arch3-
EGFP was achieved by transient transfection of HEK-293 cells with FuGENE HD
(Promega, Madison, WI, USA). Stock solutions of retinal analogues were stored in
the dark (1 mM, dissolved in isopropyl alcohol). The respective retinal analogues
were added to the dishes at a final concentration of 1 mM directly after induction/
transfection.
Recording of photocurrents. Photocurrents were determined by the whole-cell
patch-clamp technique 24–30 h after induction/transfection. A Polychrome V
(TILL Photonics, Germany) was used as the light source and controlled via
TillVision software (TILL Photonics, Germany) and a VS25 shutter (Vincent
Associates Uniblitz, USA). Action spectra were recorded at light intensities
that were directly adjusted to an equal number of photons (2.81 1014
photons s 1 mm 2) for all wavelengths using a motorized filter wheel (NSND-3,
Newport, Irvine, CA, USA). For comparison with other experiments, illumination
with blue light of 470 nm corresponded to a light intensity of 0.119 mW mm 2.
To establish action spectra for ChR2, we conducted 10-ms illuminations using
an additional 10% grey filter for each wavelength (2.81 1013 photons s 1 mm 2).
At a holding potential of  60 mV, the transient peak current was analysed to
exclude an activation of photointermediates. For the action spectra of Arch3, we
conducted 300 ms illuminations for each wavelength. Because for this pump a
transient peak was not or only barely visible, the stationary current at a holding
potential of 0 mV was analysed. To measure current amplitudes, we conducted 300-
ms illuminations and analysed stationary currents with excitation at 465±7 nm
(ChR2; all retinal analogues), 565±7 nm (Arch3; ATR), 530±7 nm (Arch3; VIII)
or 500±7 nm (Arch3; VII). Further details are given in the respective figure legends.
The external bath solution contained [mM]: 140 NaCl, 1 CaCl2, 1 KCl, 1 MgCl2 and
10 HEPES (pH 7.2 adjusted with NMG), whereas the intracellular pipette solution
contained [mM]: 110 NaCl, 10 EGTA, 5 KCl, 1 CaCl2, 1 MgCl2 and 10 HEPES
(pH 7.2 adjusted with NMG).
Behavioural assays on larval Drosophila. Third instar larvae, 5–6 days of age after
egg-laying, were used. Larvae expressing UAS:ChR2(H134R) (ref. 59) under the
control of the Actin-Gal4 driver were raised at 25 C on standard medium
containing either 125mM ATR (Sigma, Heidelberg, Germany) or DMAR, both
dissolved in ethanol (10ml of solution in 10 ml food). As a control, animals raised on
medium containing ethanol only were used. To observe light-induced muscle
contractions, individual larvae were placed on a coverslip and illuminated from
below with a custom-built illuminator containing high-power LEDs (Huey Jann,
electronics industry Co., Wu-Chi Town Taichung Shien, Taiwan) of wavelength 465,
520, 590 and 625 nm, respectively. Larvae were observed using a stereomicroscope
(Discovery.V8, Zeiss, Oberkochen, Germany) equipped with a AxioCam MRm
camera. Contractions of the whole larvae in response to light stimulation were
observed under dim white light illumination (B0.0002 mW mm 2). Muscle
contractions induced by monochromatic light were measured for each wavelength at
B0.01, B0.02, B0.07 and B0.1 mW mm 2. Light intensities were controlled with
a custom-built power supply and calibrated using a photometer (Lasercheck,
Coherent, Santa Clara, CA, USA).
Structure visualization. For structure visualizations, PyMOL (Schrödinger,
Germany), Molecular Operating Environment 2013.0802 (CCG, Canada) and
GOLD 5.2 (CCDC, UK) were used. The molecular structure files for the proteins
(PDB IDs: 3UG9 and 1VGO) and the ligand (analogue IX) were prepared in MOE.
To predict the best possible binding modes of the ligand, docking was carried out
using GOLD. The binding site was centered at the lysine residue of the protein
involved in Schiff base formation with the chromophore and all surrounding atoms
of the active-site within 20 Å were selected. The covalent bond was specified
between the e–N of the lysine of the protein and the ligand. The best protein–
ligand docked binding mode was chosen based on the CHEMPLP score. The
default docking parameters were used.
Statistics. Sample size was chosen so that the statistical significance could be
achieved within the measurement accuracy of the respective experiment. All of the
samples recorded were included in data analysis. Statistical analysis was carried out
with Microsoft Excel, Prism (GraphPad, USA) or Origin (OriginLab, USA). Sig-
nificance is given as P value after two-tailed Student’s t-test, one-way analysis of
variance with Bonferroni’s or Fisher’s post hoc test, two-way analysis of variance or
w2-test: NS not significant, *Po0.05; **Po0.01; ***Po0.001. For the elongation
experiments in C. elegans, we compared data in the time window 4.5–6.5 s of retinal
analogues to controls that were raised in the absence of any chromophore. Time
constants were obtained by non-linear fitting for monoexponential decay of body
length or inward current changes using Origin (OriginLab).
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In this Article, there are errors in the formulae depicted in Fig. 1a that were introduced during the production process. The chemical
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